Cancers, Vol. 16, Pages 419: Dkk1 as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Breast Cancer Patients
Conclusions: In this study, we demonstrated for the first time that Dkk1 could be identified as an independent predictor of NACT response in BC patients, particularly those with TNBC. Further research with a multicentric expanded (pre-/post-therapy) sample set and better-defined populations in terms of molecular subtypes, therapy modality, and long-term follow-up is recommended to obtain more solid evidence.
Source: Cancers - Category: Cancer & Oncology Authors: Kasoha Steinbach Bohle Linxweiler Haj Hamoud Doerk Nigdelis Stotz Zimmermann Solomayer Kaya Radosa Tags: Article Source Type: research
More News: Breast Cancer | Breast Carcinoma | Breast Needle Aspiration | Breast Surgery | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Women